We are live on ! Find out more
WST icon

West Pharmaceutical
WST

288 hedge funds and large institutions have $5.1B invested in West Pharmaceutical in 2016 Q2 according to their latest regulatory filings, with 56 funds opening new positions, 91 increasing their positions, 111 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 14

17% more funds holding in top 10

Funds holding in top 10: 6 → 7 (+1)

15% more funds holding

Funds holding: 250 → 288 (+38)

8% more capital invested

Capital invested by funds: $4.71B → $5.1B (+$387M)

2.25% less ownership

Funds ownership: 94.13% → 91.88% (-2.3%)

18% less repeat investments, than reductions

Existing positions increased: 91 | Existing positions reduced: 111

Holders
288
Holders Change
+38
Holders Change %
+15.2%
% of All Funds
7.68%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.19%
New
56
Increased
91
Reduced
111
Closed
14
Calls
$1.67M
Puts
–
Net Calls
+$1.67M
Net Calls Change
+$396K

Top Buyers

1
CWAM
Columbia Wanger Asset Management
Illinois
+$44.2M
2
Macquarie Group
Macquarie Group
Australia
+$29M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$20.5M
4
BIT
BlackRock Institutional Trust
California
+$18.4M
5
CS
Credit Suisse
Switzerland
+$18.1M

Top Sellers

1
BFA
BlackRock Fund Advisors
California
-$69.9M
2
State Street
State Street
Massachusetts
-$38.7M
3
Northern Trust
Northern Trust
Illinois
-$37.6M
4
Renaissance Technologies
Renaissance Technologies
New York
-$34.1M
5
RIM
RS Investment Management
California
-$24.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
ASRS
126
Arizona State Retirement System
Arizona
$2.36M -$488K -6,700 -18%
VOYA Investment Management
127
VOYA Investment Management
Georgia
$2.36M +$71.8K +987 +3%
KGI
128
KBI Global Investors
Ireland
$2.33M +$2.24M +30,760 New
NSEDCP
129
NJ State Employees Deferred Compensation Plan
New Jersey
$2.28M – – –
N
130
Nuveen
North Carolina
$2.27M -$7.35K -101 -0.3%
SOMRS
131
State of Michigan Retirement System
Michigan
$2.22M +$29.1K +400 +1%
Squarepoint
132
Squarepoint
New York
$2.22M +$2.13M +29,296 New
AAM
133
Advisors Asset Management
Colorado
$2.2M -$603K -8,288 -22%
BNP Paribas Financial Markets
134
BNP Paribas Financial Markets
France
$2.2M +$2.1M +28,924 +53,563%
AG
135
Aperio Group
California
$2M +$65.2K +896 +4%
Los Angeles Capital Management
136
Los Angeles Capital Management
California
$1.99M -$19.3K -265 -1%
Envestnet Asset Management
137
Envestnet Asset Management
Illinois
$1.99M -$74.2K -1,020 -4%
AAM
138
AMI Asset Management
California
$1.93M -$14M -192,801 -88%
CCM
139
Century Capital Management
Massachusetts
$1.9M -$619K -8,509 -25%
Jacobs Levy Equity Management
140
Jacobs Levy Equity Management
New Jersey
$1.89M +$1.81M +24,900 New
OPERF
141
Oregon Public Employees Retirement Fund
Oregon
$1.82M +$42.6K +586 +3%
WT
142
Whittier Trust
California
$1.64M +$19.1K +262 +1%
Barclays
143
Barclays
United Kingdom
$1.64M +$1.52M +20,874 +2,683%
VRS
144
Virginia Retirement Systems
Virginia
$1.64M +$1.57M +21,600 New
AL
145
Airain Ltd
Guernsey
$1.63M +$1.56M +21,427 New
SG Americas Securities
146
SG Americas Securities
New York
$1.6M -$481K -6,608 -24%
SG
147
Societe Generale
$1.6M +$1.54M +21,154 New
B
148
Barings
North Carolina
$1.6M – – –
OC
149
Oppenheimer & Co
New York
$1.56M – – –
State of Tennessee, Department of Treasury
150
State of Tennessee, Department of Treasury
Tennessee
$1.52M – – –
4 5
6
7 8

WST Hedge Fund Activity: Q2 2016 in Review

288 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q2 2016, worth a combined $5.1B — up 8.2% from $4.71B a quarter earlier.

Buyers outnumbered sellers: 56 funds opened new WST positions and 14 closed out — a net gain of 42 holders — while 91 added to existing stakes and 111 trimmed.

The largest buyer was Columbia Wanger Asset Management, adding an estimated $44.2M. The largest seller was BlackRock Fund Advisors, cutting an estimated $69.9M.

  • 288 institutional investors held West Pharmaceutical (WST) as of Q2 2016, up from 250 in Q1 2016.
  • Funds reported $5.1B of West Pharmaceutical stock for Q2 2016, up 8.2% quarter-over-quarter.
  • 56 funds opened new West Pharmaceutical positions in Q2 2016 and 14 closed out, a net change of +42 holders.
  • The largest West Pharmaceutical buyer in Q2 2016 was Columbia Wanger Asset Management, an estimated $44.2M added.
  • The largest West Pharmaceutical seller in Q2 2016 was BlackRock Fund Advisors, an estimated $69.9M sold.

Based on aggregated 13F filings for Q2 2016.